HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Constitutional dysfunction of heparin cofactor II with a tendency for venous thrombosis].

Abstract
Simultaneous determination of heparin cofactor II (HC II) immunologically as antigen (HC II:Ag) and functionally as heparin cofactor (H-HC II) and as dermatan sulfate cofactor (DS-HC II) renders possible a distinction between quantitative and qualitative deficiencies. The usefulness of these methods is demonstrated in the light of a family with several heterozygotes of quantitative HC II deficiency and two unrelated heterozygote men with defective dermatan sulfate cofactor function (DS HC II) and normal HC II:Ag and H-HC II.
AuthorsG A Marbet, B Zbinden, F Duckert
JournalSchweizerische medizinische Wochenschrift (Schweiz Med Wochenschr) Vol. 118 Issue 43 Pg. 1586-8 (Oct 29 1988) ISSN: 0036-7672 [Print] Switzerland
Vernacular TitleKonstitutionelle Dysfunktion von Heparin-Kofaktor II mit venöser Thromboseneigung.
PMID3238395 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antithrombins
  • Glycoproteins
  • Dermatan Sulfate
  • Heparin Cofactor II
Topics
  • Adolescent
  • Adult
  • Antithrombins (physiology)
  • Dermatan Sulfate (blood)
  • Female
  • Glycoproteins (deficiency, physiology)
  • Heparin Cofactor II
  • Humans
  • Male
  • Middle Aged
  • Pulmonary Embolism (physiopathology)
  • Thrombophlebitis (genetics, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: